Variant report
Variant | nsv972633 |
---|---|
Chromosome Location | chr9:136949751-136953760 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000169925 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557949484 | chr9:136949810-136949811 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs569848181 | chr9:136949818-136949819 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs115495195 | chr9:136949868-136949869 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs547445810 | chr9:136949877-136949878 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs142270253 | chr9:136949879-136949880 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs570760329 | chr9:136949886-136949887 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs150892691 | chr9:136949901-136949902 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs181074300 | chr9:136949908-136949909 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs556270277 | chr9:136949912-136949913 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs552908051 | chr9:136949952-136949953 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs577547770 | chr9:136949953-136949954 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs545024036 | chr9:136949958-136949959 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs563365973 | chr9:136949959-136949960 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs138154207 | chr9:136949972-136949973 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs542798458 | chr9:136950062-136950063 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs561073199 | chr9:136950078-136950079 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs528362104 | chr9:136950117-136950118 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs2427950 | chr9:136950118-136950119 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs370315065 | chr9:136950122-136950123 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs144310929 | chr9:136950176-136950177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs57225288 | chr9:136950209-136950210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2427951 | chr9:136950303-136950304 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs551792984 | chr9:136950347-136950348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569809800 | chr9:136950355-136950356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537149146 | chr9:136950458-136950459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs555497889 | chr9:136950466-136950467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567532987 | chr9:136950488-136950489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs78220342 | chr9:136950499-136950500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184996697 | chr9:136950505-136950506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553377453 | chr9:136950506-136950507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs77782345 | chr9:136950536-136950537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556012383 | chr9:136950546-136950547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs78752804 | chr9:136950560-136950561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572639031 | chr9:136950561-136950562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190241928 | chr9:136950568-136950569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182587506 | chr9:136950576-136950577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561037428 | chr9:136950640-136950641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528250405 | chr9:136950644-136950645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540453220 | chr9:136950646-136950647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565023503 | chr9:136950647-136950648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2506696 | chr9:136950691-136950692 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs185360049 | chr9:136950729-136950730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563350269 | chr9:136950773-136950774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533210003 | chr9:136950814-136950815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575401149 | chr9:136950821-136950822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549046431 | chr9:136950886-136950887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35259020 | chr9:136950920-136950921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201481075 | chr9:136950921-136950922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs377567310 | chr9:136950925-136950926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567457640 | chr9:136950954-136950955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Lung cancer | 19147751 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ependymoma | 19289631 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Cervical cancer | 17311676 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Chordoma | 18071362 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Kleefstra Syndrome | 21538692 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Cancer | 21183584 | CNVD |
Chronic myelomonocytic leukemia | 16760666 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Tuberous sclerosis | 19566914 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20581869 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Bladder cancer | 21909424 | CNVD |
Cancer | 17160897 | CNVD |
Ependymoma | 20639864 | CNVD |
Breast cancer | 20932292 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Idiopathic chronic pancreatitis | 21572526 | CNVD |
Kleefstra syndrome | 22670141 | CNVD |
Schizophrenia | 22241247 | CNVD |
9q deletion syndrome | 16826528 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Non-syndromic sensorineural hearing loss | 19293338 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:136949600-136951400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr9:136953000-136953200 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
3 | chr9:136953000-136953400 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr9:136953000-136953600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr9:136953000-136953600 | Enhancers | NHEK | skin |
6 | chr9:136953000-136953800 | Enhancers | Esophagus | oesophagus |
7 | chr9:136953200-136953400 | Enhancers | Gastric | stomach |
8 | chr9:136953200-136953600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr9:136953200-136953600 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr9:136953200-136953600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr9:136953200-136953600 | Bivalent Enhancer | Stomach Mucosa | stomach |
12 | chr9:136953400-136953600 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr9:136953400-136968400 | Weak transcription | Gastric | stomach |
14 | chr9:136953600-136955200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |